Company page
Uniqure N.v.
Uniqure N.V. is a public company traded on the American market under the ticker QURE. With a market capitalization of approximately $2.74 billion, Uniqure focuses on developing gene therapies for genetic diseases. The company is committed to advancing innovative treatment options to improve patient outcomes.

- Ticker
- QURE:NASDAQ
- Asset type
- Stock
- Market cap
- $3.03B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD